$89.99 $1.99 (2.3%)

08:00 PM EDT on 07/02/20

10x Genomics (NASDAQ:TXG)

CAPS Rating: No stars

Current Price $89.99 Mkt Cap $8.9B
Open $0.00 P/E Ratio 0.00
Prev. Close $89.99 Div. (Yield) $0.00 (0.0%)
Daily Range $0.00 - $0.00 Volume 584,208
52-Wk Range $45.11 - $108.36 Avg. Daily Vol. 1,001,691

Caps

How do you think NASDAQ:TXG will perform against the market?

Add Stock to CAPS Watchlist

All Players

6 Outperform
0 Underperform
 

All-Star Players

4 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:TXG Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:TXG VS S&P 500 (SPY)

NASDAQ:TXG Summary

Fools bullish on NASDAQ:TXG are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about TXG.

Recs

0
Member Avatar CBK (72.08) Submitted: 6/8/2020 10:23:30 AM : Outperform Start Price: $82.06 NASDAQ:TXG Score: +12.24

-On a mission to resolving biology to advance human health.
-A life science technology company building products to interrogate, understand & master biology
-Top-dog and first movers in their market
-Showing rapid growth in publications across life science.
-Serge (CEO) was the first employee at 23andMe, where he served as Founding Architect and Director of R&D.
-The head of the board, Dr. Stuelpnagel, was the first CEO of $ILMN

Recs

0
Member Avatar CMFBLSH (92.65) Submitted: 1/2/2020 11:25:13 AM : Outperform Start Price: $76.91 NASDAQ:TXG Score: +20.65

Single cell gene expression; Chairman of Board is Illumina co-founder; New IPO; New technology (Next GEM) doesn't have legal/patent issues that were settled with Bio-Rad on older tech (which is being phased out); settled with BDX on patent dispute as well; It is a picks and shovel play; the initial TAM is $13B according to S-1 filing, expanding to $50B longer-term;
Science magazine heralded single gene expression as the breakthrough of 2018;

Any tumor biopsy has many different cells; this technology goes to heart of a single cell DNA and spatial technology to view interactions.....

Leaderboard

Find the members with the highest scoring picks in TXG.

Score Leader

TMFSarahGen

TMFSarahGen (95.91) Score: +75.71

The Score Leader is the player with the highest score across all their picks in TXG.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFSarahGen 95.91 10/10/2019 Outperform 5Y $49.50 +81.82% +6.10% +75.71 0 Comment
sharktrade < 20 12/19/2019 Outperform 5Y $69.56 +29.37% -2.58% +31.95 0 Comment
CMFBLSH 92.65 1/2/2020 Outperform 5Y $76.91 +17.01% -3.65% +20.65 1 Comment
jck444 96.86 6/9/2020 Outperform 5Y $80.91 +11.22% -2.53% +13.75 0 Comment
CBK 72.08 6/8/2020 Outperform 5Y $82.06 +9.67% -2.57% +12.24 1 Comment
camcaid28 81.18 4/30/2020 Outperform 5Y $81.06 +11.02% +6.96% +4.06 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for TXG.